Tirosine kinase inhibitors in dogs and cats - Part 2
- Understanding mechanism of resistance of TKI
- Identify side effects of TKI
- Recognize potential new TKI treatment for different tumors
Dr. Antonio Giuliano graduated from the University of Messina in 2007. He obtained a master’s degree in Small Animal Oncology from the University of Pisa, a postgraduate certificate in cancer therapeutic at Barts Cancer Institute and the GpCert (SAM) in internal medicine.
He completed a rotating internship and an oncology internship and residency at the Queen Veterinary School Teaching Hospital (QVSH), at the University of Cambridge. Dr Antonio Giuliano is a recognised European, RCVS and HK specialist in small animal oncology.
He is currently associate Clinical professor in oncology at JCC College of Veterinary Medicine at City University of Hong Kong.
He completed a rotating internship and an oncology internship and residency at the Queen Veterinary School Teaching Hospital (QVSH), at the University of Cambridge. Dr Antonio Giuliano is a recognised European, RCVS and HK specialist in small animal oncology.
He is currently associate Clinical professor in oncology at JCC College of Veterinary Medicine at City University of Hong Kong.